Category: XD
XD recombinant
France: XD recombinant lacks a competitive advantage over BA.2
France has just published a new risk analysis for SARS-CoV-2 variants circulating in the country. The headline from the report is that the Deltacron recombinant XD is struggling to compete with Omicron BA.2.… ...More...
France: XD Deltacron recombinant update
France has issued its latest epidemiological update which gives more details on the growth and characteristics of the XD Deltacron recombinant.… ...More...
Preprint: 100% symptomatic infection with XD recombinant
“This recombinant (XD) exhibits immune escape properties similar to Omicron, while its behavior in mice expressing the human ACE2 receptor is more similar to Delta.”… ...More...
UK: XE may have a growth rate ~10% greater than Omicron BA.2 *1 UPDATE*
“Early growth rates for XE were not significantly different from BA.2, but using the most recent data up to 16 March 2022, XE has a growth rate 9.8% above that of BA.2.”… ...More...
France: XD Deltacron recombinant latest *1 UPDATE*
France has given a little more detail about the Deltacron hybrid virus found circulating in various regions there. The Delta/Omicron recombinant in France is currently referred to as XD.… ...More...
Deltacron: XD and XF recombinants now ECDC Variants under Monitoring
The European Centre for Disease Prevention and Control (ECDC) have added Deltacron recombinants XD and XF to their list of Variants under Monitoring. … ...More...
Recombination: Details on XD, XE and XF recombinants by Tom Peacock
There’s a new thread on Twitter by Tom Peacock of Imperial College covering the latest information on the SARS-CoV-2 recombinants XD, XE and XF.… ...More...